BZPEERPapers, people, evidence and research pathsDiscover
Research tools
Network
Opportunities
Account
Source author record
Simon Schneider appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.
Catalog footprint
Research graph
Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.
BZPEER is loading the nearby papers, people, topics and institutions for this page.
Published work
We propose a finite volume stochastic collocation method for the random Euler system. We rigorously prove the convergence of random finite volume solutions under the assumption that the discrete differential quotients remain bounded in probability. Convergence analysis combines results on the convergence of a deterministic FV method with stochastic compactness arguments due to Skorokhod and Gyöngy-Krylov.
Applying the concept of S-convergence, based on averaging in the spirit of Strong Law of Large Numbers, the vanishing viscosity solutions of the Euler system are studied. We show how to efficiently compute a viscosity solution of the Euler system as the S-limit of numerical solutions obtained by the Viscosity Finite Volume method. Theoretical results are illustrated by numerical simulations of the Kelvin--Helmholtz instability problem.
Background: Recent studies have shown a decrease in annualised relapse rates (ARRs) in placebo groups of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS). Methods: We conducted a systematic literature search of RCTs in RMS. Data on eligibility criteria and baseline characteristics were extracted and tested for significant trends over time. A meta-regression was conducted to estimate their contribution to the decrease of trial ARRs over time. Results: We identified 56 studies. Patient age at baseline (p < 0.001), mean duration of multiple sclerosis (MS) at baseline (p = 0.048), size of treatment groups (p = 0.003), Oxford Quality Scale scores (p = 0.021), and the number of eligibility criteria (p<0.001) increased significantly, whereas pre-trial ARR (p = 0.001), the time span over which pre-trial ARR was calculated (p < 0.001), and the duration of placebo-controlled follow-up (p = 0.006) decreased significantly over time. In meta-regression of trial placebo ARR, the temporal trend was found to be insignificant, with major factors explaining the variation: pre-trial ARR, the number of years used to calculate pre-trial ARR and study duration. Conclusion: The observed decline in trial ARRs may result from decreasing pre-trial ARRs and a shorter time period over which pre-trial ARRs were calculated. Increasing patient age and duration of illness may also contribute.
A modified version of a micro scale atmospheric pressure plasma jet (μ-APPJ) source, so-called X-Jet, is used to study the role of plasma generated VUV photons in the inactivation of E. coli bacteria. The plasma is operated in He gas or a He/O2 mixture and the X-Jet modification of the jet geometry allows effective separation of heavy reactive particles (such as O atoms or ozone molecules) from the plasma-generated photons. The measurements of the evolution of zone of inhibitions formed in monolayers of vegetative E. coli bacteria, of VUV emission intensity and of positive ion spectra show that photochemistry in the gas phase followed by photochemistry products impacting on bacteria can result in bacterial inactivation. Interestingly, this process is more effective than direct inactivation by VUV radiation damage. Mainly protonated water cluster ions are detected by mass spectrometry indicating that water impurity has to be carefully considered. The measurements indicate that the combination of the presence of water cluster ions and O2 molecules at the surface leads to the strongest effect. Additionally, it seem that the interaction of VUV photons with effluent of He/O2 plasma leads to enhanced formation of O3, which is not the case when only O2 molecules and gas impurities at room temperature interacts with plasma generated VUV photons.